Kristin Jensen

Publication Details

  • New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up.

    Jensen KC, Turbin DA, Leung S, Miller MA, Johnson K, Norris B, Hastie T, McKinney S, Nielsen TO, Huntsman DG, Gilks CB, West RB. Breast Cancer Res Treat. 2008; 112 (3): 453-9

    HER2 gene amplification and/or protein overexpression in breast cancer is associated with a poor prognosis and predicts response to anti-HER2 therapy. We examine the natural history of breast cancers in relationship to increased HER2 copy numbers in a large population-based study.

    PubMedID: 18193353

Stanford Medicine Resources:

Footer Links: